Body Diffusion-weighted MR Imaging in Oncology: Imaging at 3 T.

Advances in hardware and software enable high-quality body diffusion-weighted images to be acquired for oncologic assessment. 3.0 T affords improved signal/noise for higher spatial resolution and smaller field-of-view diffusion-weighted imaging (DWI). DWI at 3.0 T can be applied as at 1.5 T to improve tumor detection, disease characterization, and the assessment of treatment response. DWI at 3.0 T can be acquired on a hybrid PET-MR imaging system, to allow functional MR information to be combined with molecular imaging.

[1]  D. Yeung,et al.  Non-Gaussian Analysis of Diffusion Weighted Imaging in Head and Neck at 3T: A Pilot Study in Patients with Nasopharyngeal Carcinoma , 2014, PloS one.

[2]  A. Wetter,et al.  Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [18F] Choline PET/MRI , 2014, PloS one.

[3]  M. Forsting,et al.  Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system? , 2013, European journal of radiology.

[4]  Bong Joo Kang,et al.  Readout-segmented echo-planar imaging in diffusion-weighted mr imaging in breast cancer: comparison with single-shot echo-planar imaging in image quality. , 2014 .

[5]  Dwight G. Nishimura,et al.  Clinical Evaluation of Reduced Field-of-View Diffusion-Weighted Imaging of the Cervical and Thoracic Spine and Spinal Cord , 2012, American Journal of Neuroradiology.

[6]  Y. Ohgiya,et al.  Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. , 2014, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[7]  M. Forsting,et al.  Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection? , 2013, European journal of radiology.

[8]  Y. Jeong,et al.  Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: Diffusion‐weighted 3 tesla MR imaging , 2012, Journal of magnetic resonance imaging : JMRI.

[9]  G. Adam,et al.  MR Imaging of Prostate Cancer: Diffusion Weighted Imaging and (3D) Hydrogen 1 (1H) MR Spectroscopy in Comparison with Histology , 2010, Radiology research and practice.

[10]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[11]  D. Porter,et al.  Readout-segmented echo-planar imaging for diffusion-weighted imaging in the pelvis at 3T-A feasibility study. , 2014, Academic radiology.

[12]  Magalie Viallon,et al.  Improvement of renal diffusion-weighted magnetic resonance imaging with readout-segmented echo-planar imaging at 3T. , 2015, Magnetic resonance imaging.

[13]  T. Metens,et al.  What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.

[14]  C. Kim,et al.  Prediction of locally recurrent prostate cancer after radiation therapy: Incremental value of 3T diffusion‐weighted MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[15]  D. Collins,et al.  Assessing response in bone metastases in prostate cancer with diffusion weighted MRI , 2011, European Radiology.

[16]  P. Boesiger,et al.  High-resolution diffusion tensor imaging of prostate cancer using a reduced FOV technique. , 2011, European journal of radiology.

[17]  M. Okada,et al.  [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.

[18]  Emmanuel Itti,et al.  Whole-Body Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Treatment Response Assessment in Patients With Diffuse Large B-Cell Lymphoma: Pilot Study , 2011, Investigative radiology.

[19]  H. Eskola,et al.  Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B‐cell lymphoma – a whole‐body MRI and diffusion‐weighted imaging study , 2013, NMR in biomedicine.

[20]  A. Stecco,et al.  Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases , 2013, La radiologia medica.

[21]  S. Skare,et al.  Readout-segmented EPI for rapid high resolution diffusion imaging at 3 T. , 2008, European journal of radiology.

[22]  D. Collins,et al.  Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. , 2012, AJR. American journal of roentgenology.

[23]  D. Alain,et al.  Whole-body diffusion-weighted MRI for staging lymphoma at 3.0T: comparative study with MR imaging at 1.5T. , 2015, Clinical imaging.

[24]  B. Seifert,et al.  Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. , 2014, Radiology.

[25]  M. Fenchel,et al.  Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results. , 2011, AJR. American journal of roentgenology.

[26]  Dwight G Nishimura,et al.  Hadamard slice encoding for reduced‐FOV diffusion‐weighted imaging , 2014, Magnetic resonance in medicine.

[27]  S. Dymarkowski,et al.  Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT , 2014, European Radiology.

[28]  H. Chandarana,et al.  PET/MRI for the evaluation of patients with lymphoma: initial observations. , 2015, AJR. American journal of roentgenology.

[29]  G. Johnson,et al.  Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. , 2012, Radiology.

[30]  High-Resolution Diffusion-Weighted Imaging of Neck Lymph Nodes Using 2D-Single-Shot Interleaved Multiple Inner Volume Imaging Diffusion-Weighted Echo-Planar Imaging at 3T , 2011, American Journal of Neuroradiology.

[31]  A. Ba-Ssalamah,et al.  Confident non-invasive diagnosis of pseudolesions of the liver using diffusion-weighted imaging at 3T MRI. , 2012, European journal of radiology.

[32]  Robin M Heidemann,et al.  High resolution diffusion‐weighted imaging using readout‐segmented echo‐planar imaging, parallel imaging and a two‐dimensional navigator‐based reacquisition , 2009, Magnetic resonance in medicine.

[33]  L. Fayad,et al.  Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis , 2013, ISRN radiology.

[34]  A. Chhabra,et al.  Anatomic MR Imaging and Functional Diffusion Tensor Imaging of Peripheral Nerve Tumors and Tumorlike Conditions , 2013, American Journal of Neuroradiology.

[35]  Hee Jung Shin,et al.  Comparison of readout segmented echo planar imaging (EPI) and EPI with reduced field‐of‐VIew diffusion‐weighted imaging at 3t in patients with breast cancer , 2015, Journal of magnetic resonance imaging : JMRI.

[36]  S. Skare,et al.  Robust GRAPPA‐accelerated diffusion‐weighted readout‐segmented (RS)‐EPI , 2009, Magnetic resonance in medicine.

[37]  B. K. Park,et al.  Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy , 2008, Investigative Radiology.

[38]  A. Wetter,et al.  Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis , 2014, Annals of Nuclear Medicine.

[39]  H. Merisaari,et al.  Evaluation of different mathematical models for diffusion‐weighted imaging of normal prostate and prostate cancer using high b‐values: A repeatability study , 2015, Magnetic resonance in medicine.

[40]  T. Tsuchida,et al.  Evaluation of staging and early response to chemotherapy with whole‐body diffusion‐weighted MRI in malignant lymphoma patients: A comparison with FDG‐PET/CT , 2015, Journal of magnetic resonance imaging : JMRI.

[41]  Byung Kwan Park,et al.  Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results , 2007, Investigative radiology.

[42]  Robert Turner,et al.  Diffusion imaging in humans at 7T using readout‐segmented EPI and GRAPPA , 2010, Magnetic resonance in medicine.

[43]  Takeshi Yoshikawa,et al.  Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) , 2012, Journal of magnetic resonance imaging : JMRI.

[44]  C. Geppert,et al.  Zoomed echo-planar imaging using parallel transmission: impact on image quality of diffusion-weighted imaging of the prostate at 3T , 2014, Abdominal Imaging.

[45]  Zhaoqin Huang,et al.  Diffusion-weighted imaging of prostate cancer on 3T MR: Relationship between apparent diffusion coefficient values and Ki-67 expression. , 2013, Academic radiology.

[46]  Timothy D Johnson,et al.  Multi‐system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice‐water phantom , 2013, Journal of magnetic resonance imaging : JMRI.

[47]  G. Morgan,et al.  Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. , 2014, Radiology.

[48]  P. Heusch,et al.  Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Lymph Node Metastases of Non-Small Cell Lung Cancer (NSCLC) Patients Using Hybrid 18F-FDG PET/MRI , 2015, PloS one.

[49]  T. Helbich,et al.  Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T. , 2015, Radiology.

[50]  Wolfgang Bogner,et al.  Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T. , 2012, Radiology.

[51]  Laurence Collette,et al.  Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? , 2012, European urology.

[52]  A. Cotten,et al.  Assessment of reduced field of view in diffusion tensor imaging of the lumbar nerve roots at 3 T , 2013, European Radiology.

[53]  J. Deasy,et al.  Repeatability Investigation of Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging on Thyroid Glands , 2015, Journal of computer assisted tomography.

[54]  V. Taviani,et al.  3T diffusion-weighted MRI of the thyroid gland with reduced distortion: preliminary results. , 2013, The British journal of radiology.

[55]  Yu-Dong Zhang,et al.  Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer. , 2015, Urologic oncology.

[56]  C. Geppert,et al.  Diffusion-weighted imaging of the liver: comparison of image quality between monopolar and bipolar acquisition schemes at 3T , 2015, Abdominal Imaging.

[57]  M. Rengo,et al.  Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging , 2012, Abdominal Imaging.

[58]  S. Schoenberg,et al.  Feasibility study of computed vs measured high b-value (1400 s/mm²) diffusion-weighted MR images of the prostate. , 2014, World journal of radiology.

[59]  Josef Pfeuffer,et al.  Diffusion-weighted MRI of the Prostate: Advantages of Zoomed EPI with Parallel-transmit-accelerated 2D-selective Excitation Imaging , 2014, European Radiology.

[60]  Takeo Ishigaki,et al.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.

[61]  L. Fayad,et al.  Differentiation of benign and malignant skeletal lesions with quantitative diffusion weighted MRI at 3T. , 2015, European journal of radiology.

[62]  Peter Boesiger,et al.  Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations. , 2010, Radiology.

[63]  Baris Turkbey,et al.  Comparison of calculated and acquired high b value diffusion-weighted imaging in prostate cancer , 2015, Abdominal Imaging.

[64]  P. Boesiger,et al.  Reduced field‐of‐view MRI using outer volume suppression for spinal cord diffusion imaging , 2007, Magnetic resonance in medicine.

[65]  G. Zaharchuk,et al.  Reduced Field-of-View Diffusion Imaging of the Human Spinal Cord: Comparison with Conventional Single-Shot Echo-Planar Imaging , 2011, American Journal of Neuroradiology.

[66]  T. Yen,et al.  Detection of lymph node metastasis in cervical and uterine cancers by diffusion‐weighted magnetic resonance imaging at 3T , 2008, Journal of magnetic resonance imaging : JMRI.

[67]  D. Porter,et al.  Readout-Segmented Echo-Planar Imaging in Diffusion-Weighted MR Imaging in Breast Cancer: Comparison with Single-Shot Echo-Planar Imaging in Image Quality , 2014, Korean journal of radiology.

[68]  H. Rusinek,et al.  Whole‐lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy , 2015, Journal of magnetic resonance imaging : JMRI.

[69]  D. Collins,et al.  Assessment of Treatment Response by Total Tumor Volume and Global Apparent Diffusion Coefficient Using Diffusion-Weighted MRI in Patients with Metastatic Bone Disease: A Feasibility Study , 2014, PloS one.

[70]  B. K. Park,et al.  Diffusion-Weighted Imaging of the Prostate at 3 T for Differentiation of Malignant and Benign Tissue in Transition and Peripheral Zones: Preliminary Results , 2007, Journal of computer assisted tomography.

[71]  C. Geppert,et al.  Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. , 2013, AJR. American journal of roentgenology.

[72]  Dow-Mu Koh,et al.  Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[73]  A. Padhani,et al.  Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care? , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[74]  A. Padhani,et al.  Diffusion MR imaging for monitoring of treatment response. , 2011, Magnetic resonance imaging clinics of North America.

[75]  Y. Ohgiya,et al.  Utility of apparent diffusion coefficients in the evaluation of solid renal tumors at 3T. , 2014, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[76]  D. Collins,et al.  Therapy monitoring of skeletal metastases with whole‐body diffusion MRI , 2014, Journal of magnetic resonance imaging : JMRI.

[77]  Valentina Taviani,et al.  Assessment of tumor morphology on diffusion‐weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI , 2015, Journal of magnetic resonance imaging : JMRI.

[78]  Ke Sheng,et al.  Correlation of Gleason Scores with Diffusion-Weighted Imaging Findings of Prostate Cancer , 2011, Advances in urology.

[79]  C. Lehman,et al.  Improved B1 homogeneity of 3 tesla breast MRI using dual‐source parallel radiofrequency excitation , 2012, Journal of magnetic resonance imaging : JMRI.

[80]  Dwight G Nishimura,et al.  High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer. , 2012, Academic radiology.

[81]  John Kurhanewicz,et al.  Reduced-FOV excitation decreases susceptibility artifact in diffusion-weighted MRI with endorectal coil for prostate cancer detection. , 2015, Magnetic resonance imaging.

[82]  C. Kim,et al.  Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. , 2010, AJR. American journal of roentgenology.

[83]  D. Choi,et al.  Endometrial cancer: Utility of diffusion‐weighted magnetic resonance imaging with background body signal suppression at 3T , 2013, Journal of magnetic resonance imaging : JMRI.

[84]  G. Martinelli,et al.  Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin’s lymphoma for staging and treatment response , 2014, Ecancermedicalscience.